This is a preprint.
Single cell atlas of kidney cancer endothelial cells reveals distinct expression profiles and phenotypes
- PMID: 37986984
- PMCID: PMC10659545
- DOI: 10.21203/rs.3.rs-3558517/v1
Single cell atlas of kidney cancer endothelial cells reveals distinct expression profiles and phenotypes
Update in
-
Single cell atlas of kidney cancer endothelial cells reveals distinct expression profiles and phenotypes.BJC Rep. 2024 Mar 14;2(1):23. doi: 10.1038/s44276-024-00047-9. BJC Rep. 2024. PMID: 39516665 Free PMC article.
Abstract
Background: Tumor endothelial cells (TECs) represent the primary interface between the tumor microenvironment and circulating immune cells, however their phenotypes are incompletely understood in highly vascularized clear cell renal cell carcinoma (ccRCC).
Methods: We purified tumor and matched normal endothelial cells (NECs) from ccRCC specimens and performed single-cell RNA-sequencing to create a reference-quality atlas available as a searchable web resource for gene expression patterns. We established paired primary TECs and NECs cultures for ex vivo functional testing.
Results: TECs from multiple donors shared a common phenotype with increased expression of pathways related to extracellular matrix regulation, cell-cell communication, and insulin-like growth factor signaling that was conserved in comparison to hepatocellular carcinoma associated TECs, suggesting convergent TEC phenotypes between unrelated tumors. Cultured TECs stably maintained a core program of differentially regulated genes, were inherently resistant to apoptosis after vascular endothelial growth factor removal and displayed increased adhesiveness to subsets of immune cells including regulatory T-cells.
Conclusions: Our studies delineate unique functional and phenotypic properties of TECs, which may provide insights into their interactions with available and emerging therapies. Functional phenotypes of cultured TECs suggest potential mechanisms of resistance to both antiangiogenic and immune-based therapies.
Keywords: Endothelial cells; Immune cell adhesion; Renal cell carcinoma; Single-cell RNA sequencing.
Conflict of interest statement
Additional Declarations: No competing interests reported. Competing Interests The authors have no conflicts of interest to declare.
Figures
References
-
- Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394(6692):485–90. - PubMed
-
- Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 1994;7(1):85–90. - PubMed
-
- Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292(5516):464–8. - PubMed
-
- Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292(5516):468–72. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
